Decoding IgA Nephropathy: From Suspicion to Solution
Jonathan Barratt, MD, PhD
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
Navigating KDIGO Guidance in IgAN
The Evolving Role of Biomarkers in IgAN
Translating Evidence into IgAN Care
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Unmasking IgAN: Achieving Earlier Diagnosis
The Future of IgAN Care
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Gabapentinoids: Safety Considerations and Downstream Outcomes
Reading Between the Lines: What PROMs Reveal About Itch
Spotlight on Assessment: Tools That Capture CKD-aP
CKD-aP Uncovered Prevalence & Pathophysiology
When Itching Hurts: Quality of Life Disruption in CKD-aP